Get started
RocketTickers

Recursion is Granted FDA Fast Track Designation for REC-2282 for

Long
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)  
RocketTickers  
NASDAQ:RXRX   Recursion Pharmaceuticals, Inc.
Beyond Technical Analysis
0
0
beyondta
RXRX: Recursion Pharmaceuticals, Inc.
2021-10-07 07:55:00
Recursion is Granted FDA Fast Track Designation for REC-2282 for the Potential Treatment of NF2-Mutated Meningiomas
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.